5 simple steps for targeting a £1,000,000 SIPP

Through regular contributions and careful monitoring, investors can target a seven-figure long-term SIPP to improve their retirement quality of life.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A senior group of friends enjoying rowing on the River Derwent

Image source: Getty Images

Leveraging the power of a Self-Invested Personal Pension (SIPP) is one of the best ways to start building retirement wealth in the stock market. And looking at the latest data from the Office for National Statistics, it’s a step that many Britons may need to consider.

The average pension savings among 60-year-olds is £228,200 for men and £152,600 for women. Yet following the 4% withdrawal rule, that’s barely enough to generate the £14,400 recommended by the Pensions and Lifetime Savings Association to maintain a minimum retirement lifestyle, let alone a moderate or comfortable one.

With that in mind, let’s explore how investors can leverage a SIPP to try and build a £1m pension pot.

How to start

  1. Open a SIPP
  2. Deposit capital regularly
  3. Research investment opportunities
  4. Buy and hold for the long run
  5. Monitor and review

Different SIPP providers charge different fees, and it’s important to compare to find the most suitable platform. It’s also essential to regularly allocate money from a monthly paycheque to a SIPP so there’s capital available to buy quality shares.

Researching investment opportunities is where a lot of hiccups can occur. And for investors who don’t have the time, knowledge, or interest in picking individual stocks, an index fund might be a more suitable approach.

Once the investment decisions have been made, it’s just a matter of executing the trades and holding on for the long run. But of course, investors need to keep their fingers on the pulse to make sure their investment thesis isn’t slowly breaking.

Aiming for a million

Thanks to the tax relief provided by a SIPP, a lot of capital can be built quickly. For example, let’s say an investor’s contributing £500 a month into their pension pot. After tax relief, they could have anywhere between £625 and £1,100, depending on their income tax bracket.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Given enough time, it’s not that difficult to turn £625 a month into £1m. For example, the FTSE 100 has historically provided an average annual return of 8%. And investing £625 a month at this rate would reach £1m within 31 years.

But with stock picking, it’s possible to unlock an even higher return and shorten this journey considerably. Take AstraZeneca (LSE:AZN) as an example.

Today, the healthcare group’s one of the leading forces in cancer therapy, and novel drugs are being used worldwide. But 20 years ago, it was still an up-and-coming pharmaceutical business with a promising pipeline of medicines. Investors who saw the opportunity and capitalised on it have since enjoyed a 13% annualised return.

At this rate, the journey to a million would only take 23 years. And for those happy waiting for the full 30, their SIPPs could reach almost £3m!

Replicating this growth trajectory for new shareholders is likely going to be a challenge with AstraZeneca. After all, even with its impressive current pipeline of drugs, growth is much harder being a £165bn market-cap company. And all it takes is one unfavourable clinical trial result for a new blockbuster drug to send the share price plummeting.

However, it goes to show that by buying and holding quality businesses for the long run, investors can potentially reap tremendous returns.

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British Airways cabin crew with mobile device
Investing Articles

IAG shares have slumped 6%, so is this a dip-buying opportunity?

IAG shares have on Monday (2 March) slumped to their lowest level for the year. Are they now too cheap…

Read more »

Satellite on planet background
Investing Articles

2 top UK defence shares and an ETF to consider buying as geopolitical instability hits the stock market

Can UK investors afford to ignore defence shares given the extremely unstable geopolitical environment across the world today?

Read more »

Investing Articles

Barclays and HSBC shares are plunging today – is this my moment?

Harvey Jones holds Lloyds, but has been wary of buying Barclays and HSBS shares too because they've done a little…

Read more »

Portrait of a boy with the map of the world painted on his face.
Investing Articles

The BP and Shell share price are soaring today – are we looking at another massive spike?

As Middle East tensions explode, the BP and Shell share price are inevitably back in the spotlight. Harvey Jones looks…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

1 of my top FTSE 100 stocks just fell back into value territory. I’m buying

Instability in Iran has send Informa’s share price down 10% in a day. But Stephen Wright's adding it to his…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

An 8.7% forecast dividend yield! 1 of the best FTSE income stocks to buy today?

This FTSE 100 financial sector gem’s soaring payouts make it one of the most overlooked stocks to buy for huge…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Here’s why Lloyds shares look 42% undervalued to me right now

Lloyds' shares have cooled lately, yet its earnings momentum and upgraded targets suggest that the real move higher in price…

Read more »

Stacks of coins
Investing Articles

Here’s how I’m aiming for £20,698 in yearly income from £20,000 in this 8.4%-yielding FTSE dividend beast

This ultra-high-yield FTSE stock looks set for strong earnings growth — and its long-term dividend power could be far greater…

Read more »